Evidence map›Paper›PMID 40475426›Full record

ArticlebioRxiv : the preprint server for biology2025

Archaeal SegAB forms a bipolar structure that promotes chromosome segregation in spherical cells.

Arthur Charles-Orszag, Samuel J Lord, Nadia Herrera, Luke Strauskulage, Arghya Bhowmick, Tom Goddard, Bianca Wassmer, Marleen van Wolferen, Garrison Asper, Amy Flis and 5 more

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Arthur Charles-OrszagDepartment of Cellular and Molecular Pharmacology, Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, CA, USA.ORCID 0000-0002-5185-4124
Samuel J LordDepartment of Cellular and Molecular Pharmacology, Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, CA, USA.ORCID 0000-0002-2785-989X
Nadia HerreraDepartment of Medicine, University of California San Francisco, San Francisco, California, USA.ORCID 0000-0003-4157-9429
Luke StrauskulageDepartment of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA.
Arghya BhowmickDepartment of Cellular and Molecular Pharmacology, Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, CA, USA.
Tom GoddardDepartment of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.
Bianca WassmerMolecular Biology of Archaea, Faculty of Biology, Institute of Biology II, University of Freiburg, Freiburg, Germany.
Marleen van WolferenMolecular Biology of Archaea, Faculty of Biology, Institute of Biology II, University of Freiburg, Freiburg, Germany.
Garrison AsperDepartment of Cellular and Molecular Pharmacology, Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, CA, USA.
Amy FlisDepartment of Cellular and Molecular Pharmacology, Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, CA, USA.
Johnny RodriguezDepartment of Cellular and Molecular Pharmacology, Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, CA, USA.
Sy ReddingDepartment of Biochemistry and Biophysics, University of California San Francisco, San Francisco, CA, USA.
Oren RosenbergDepartment of Medicine, University of California San Francisco, San Francisco, California, USA.
Sonja-Verena AlbersMolecular Biology of Archaea, Faculty of Biology, Institute of Biology II, University of Freiburg, Freiburg, Germany.
R Dyche MullinsDepartment of Cellular and Molecular Pharmacology, Howard Hughes Medical Institute, University of California, San Francisco, San Francisco, CA, USA.ORCID 0000-0002-0871-5479

Funding

MUTIDISCIPLINARY TRAINING PROGRAM IN LUNG DISEASEST32HL007185 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI David J Erle, LAURENCE HUANG · 1985 to 2026
$24.6M
ChimeraX -- Next Generation Visualization and Analysis Software for Multiscale ModelingR01GM129325 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FERRIN, THOMAS E · 2018 to 2025
$5.2M
Assembly and function of cytoskeletal systems in eukaryotic and prokaryoticcellsR35GM118119 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MULLINS, R DYCHE · 2016 to 2025
$4.8M
Physical determinants of DNA recognition and genome organization in crowded environmentsR35GM147477 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Sy Redding · 2022 to 2026
$2.1M
NHLBI NIH HHS T32 HL007185NIGMS NIH HHS R01 GM129325NIGMS NIH HHS R35 GM118119NIGMS NIH HHS R35 GM147477
6 · The paper itself

Abstract

Archaeal

Identifiers

PMID40475426
PMCPMC12139799

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.